SANOFI CONSUMER HEALTHCARE INDIA
|
The Current P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA is 13.39.
| Share Price | ₹4,647.9 | Dec 08,2025 |
| Market Cap | ₹10,690.1 Cr | |
| Sales-TTM | ₹798.1 Cr | TTM-Standalone Results |
| Price/Sales | 13.39x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SANOFI CONSUMER HEALTHCARE INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹10,690.1 Cr] as on Dec 08,2025
(/) Sales [ ₹798.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 13.39x ]
Thus, for SANOFI CONSUMER HEALTHCARE INDIA , the investors are currently willing to pay '13.39 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI CONSUMER HEALTHCARE INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI CONSUMER HEALTHCARE INDIA
PS Ratio Performance Analysis for SANOFI CONSUMER HEALTHCARE INDIA
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio for fiscal years ending Dec2024 to Dec2023 averaged 7.82x.
- SANOFI CONSUMER HEALTHCARE INDIA 's operated at median p/e ratio of 15.64x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio peaked in Dec2024 at 15.64x.
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio hit its five-year low in Dec2023 of 0x.
How does SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SANOFI CONSUMER HEALTHCARE INDIA | 798.1 | 13.39 | 10,690.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.84 | 430,753.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.75 | 167,998.0 |
| CIPLA LTD | 28,349.6 | 4.27 | 120,960.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.38 | 127,186.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.08 | 105,759.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.64 | 90,210.3 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.80 | 93,011.2 |
| LUPIN LTD | 24,750.7 | 3.82 | 94,611.4 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.10 | 68,340.0 |
| ABBOTT INDIA LTD | 6,714.4 | 9.06 | 60,815.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.10x |
| Max industry PS | 16.75x |
| Median industry PS | 6.64x |
| Average industry PS | 7.38x |
You may also like the below Video Courses